EASL Studio Podcast: Liver cancer in 2022: Wrap-up & outlook
EASL Podcasts - A podcast by European Association for the Study of the Liver - Thursdays
Results from current clinical trials are rapidly evolving, with mixed results. In this EASL Studio the faculty discuss: why certain trials have failed whereas others have succeeded,what we have learned about the connection between overall survival and progression-free survival as endpoints, andhow the systemic therapy of HCC has evolved.Faculty Prof. Peter Galle (Moderator)Prof. Bruno Sangro (Faculty)Dr Anna Saborowski (Faculty)Prof. Arndt Vogel (Faculty)Related episodes S2E15 – JHEP Live – T...
